These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease. Burton KA; Ashack KA; Khachemoune A Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187 [TBL] [Abstract][Full Text] [Related]
3. An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma. O'Bryan K; Sherman W; Niedt GW; Taback B; Manolidis S; Wang A; Ratner D J Am Acad Dermatol; 2013 Oct; 69(4):595-602.e1. PubMed ID: 23871719 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ; Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687 [TBL] [Abstract][Full Text] [Related]
5. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Veness MJ; Porceddu S; Palme CE; Morgan GJ Head Neck; 2007 Jul; 29(7):621-31. PubMed ID: 17230560 [TBL] [Abstract][Full Text] [Related]
6. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695 [TBL] [Abstract][Full Text] [Related]
7. Update on the management of high-risk squamous cell carcinoma. LeBoeuf NR; Schmults CD Semin Cutan Med Surg; 2011 Mar; 30(1):26-34. PubMed ID: 21540018 [TBL] [Abstract][Full Text] [Related]
8. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors. Que SKT; Zwald FO; Schmults CD J Am Acad Dermatol; 2018 Feb; 78(2):249-261. PubMed ID: 29332705 [TBL] [Abstract][Full Text] [Related]
9. Cutaneous squamous cell carcinoma staging may influence management in users: A survey study. Patel VA; McCullum C; Sparks AD; Schmults CD; Arron ST; Jambusaria-Pahlajani A Cancer Med; 2022 Jan; 11(1):94-103. PubMed ID: 34796670 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. Jambusaria-Pahlajani A; Kanetsky PA; Karia PS; Hwang WT; Gelfand JM; Whalen FM; Elenitsas R; Xu X; Schmults CD JAMA Dermatol; 2013 Apr; 149(4):402-10. PubMed ID: 23325457 [TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis. Thompson AK; Kelley BF; Prokop LJ; Murad MH; Baum CL JAMA Dermatol; 2016 Apr; 152(4):419-28. PubMed ID: 26762219 [TBL] [Abstract][Full Text] [Related]
12. The incidence and risk factors of metastasis for cutaneous squamous cell carcinoma--implications on the T-classification system. Brougham ND; Tan ST J Surg Oncol; 2014 Dec; 110(7):876-82. PubMed ID: 25088537 [TBL] [Abstract][Full Text] [Related]
13. A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. Farasat S; Yu SS; Neel VA; Nehal KS; Lardaro T; Mihm MC; Byrd DR; Balch CM; Califano JA; Chuang AY; Sharfman WH; Shah JP; Nghiem P; Otley CC; Tufaro AP; Johnson TM; Sober AJ; Liégeois NJ J Am Acad Dermatol; 2011 Jun; 64(6):1051-9. PubMed ID: 21255868 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging. Que SKT; Zwald FO; Schmults CD J Am Acad Dermatol; 2018 Feb; 78(2):237-247. PubMed ID: 29332704 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma and proposal of a new staging system. Dinehart SM; Peterson S Dermatol Surg; 2005 Nov; 31(11 Pt 1):1379-84. PubMed ID: 16416604 [TBL] [Abstract][Full Text] [Related]
16. Analysis and comparison of the 7th edition American Joint Committee on Cancer (AJCC) nodal staging system for metastatic cutaneous squamous cell carcinoma of the head and neck. Clark JR; Rumcheva P; Veness MJ Ann Surg Oncol; 2012 Dec; 19(13):4252-8. PubMed ID: 22805870 [TBL] [Abstract][Full Text] [Related]
17. Understanding and use of the American Joint Committee on Cancer seventh edition guidelines for cutaneous squamous cell carcinoma: a survey of dermatologic surgeons. LeBlanc KG; Monheit GD Dermatol Surg; 2014 May; 40(5):505-10. PubMed ID: 24479755 [TBL] [Abstract][Full Text] [Related]
18. Systematic review of the prevalence of nodal metastases and the prognostic utility of sentinel lymph node biopsy in cutaneous squamous cell carcinoma. Tejera-Vaquerizo A; García-Doval I; Llombart B; Cañueto J; Martorell-Calatayud A; Descalzo-Gallego MA; Sanmartín O J Dermatol; 2018 Jul; 45(7):781-790. PubMed ID: 29701281 [TBL] [Abstract][Full Text] [Related]
19. Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeons. Jambusaria-Pahlajani A; Hess SD; Katz KA; Berg D; Schmults CD Arch Dermatol; 2010 Nov; 146(11):1225-31. PubMed ID: 21079057 [TBL] [Abstract][Full Text] [Related]
20. Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system. Schmitt AR; Brewer JD; Bordeaux JS; Baum CL JAMA Dermatol; 2014 Jan; 150(1):19-24. PubMed ID: 24226651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]